SCHEMBL6608556

SCHEMBL6608556

COc1ccc(NCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)c(N)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.58
▸ HTR2A P28223 3/20 0.58
▸ HTR2C P28335 2/20 0.58
▸ HTR7 P34969 2/20 0.58
▸ HTR6 P50406 2/20 0.58
▸ LMNA P02545 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ SIGMAR1 Q99720 2/20 0.52
▸ TSHR P16473 3/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21669330 0.84 SIGMAR1 (0.59) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL960296 0.83 MEN1 (0.43) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL7550023 0.83 TSHR (0.57) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL8159313 0.78 DRD2 (0.56) HTR1AHTR7LMNASIGMAR1TSHR
SCHEMBL11286821 0.76 SIGMAR1 (0.64) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL11280038 0.76 HTR2A (0.62) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL11280042 0.75 LMNA (0.74) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL11150239 0.74 SIGMAR1 (0.62) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL11439568 0.74 DRD3 (0.65) HTR1AHTR2AHTR2CHTR7HTR6
SCHEMBL4933850 0.73 DRD3 (0.80) HTR1AHTR2AHTR2CHTR7HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218352-B1 BENZIMIDAZOLONE DERIVATIVES HAVING MIXED SEROTONINE AND DOPAMINE RECEPTORS AFFINITY BOEHRINGER INGELHEIM ITALIA (IT) 2004-05-12 — — EP disclosed
US-6281218-B1 USEFUL IN THE TREATMENT OF CNS DISORDERS. INGELHEIM ITALIA S.P.A. (IT) 2001-08-28 — — US disclosed
Send feedback